Abstract
Objectives
Physicians are frequently confronted with patients suffering from aortic stenosis with annular diameters exceeding dimensions in which currently available transcatheter heart valves (THV) are formally approved. Experience in patients receiving significantly undersized Sapien 3 (S3) THV (Edwards Lifesciences, Inc., Irvine, CA, USA) in aortic annuli up to 32 mm has not been reported so far.
Methods
Patients with aortic annuli exceeding the formally determined upper size limit and who received a 29 mm S3, were identified from our database. Calcification pattern and annulus dimension were analyzed retrospectively using the 3mensio Medical Imaging software. Clinical endpoints were adjudicated in accordance with the updated standardized VARC-2 definitions.
Results
21 consecutive patients with aortic annuli ≥28.1 mm received a 29 mm THV. All patients were male (77.4 ± 8.1 year, logEuroSCORE I 22.5 ± 14.1 %). Multi-slice computed tomography and transesophageal echocardiography derived annular dimensions were 30.2 ± 1.5 vs. 28.8 ± 0.9 mm (p = 0.0001). Total calcium load of the aortic valves was 1327 ± 957 mm3. Device success according to VARC-2 definitions was achieved in 100 % (21/21). All-cause 30-day mortality was 0 % (0/21). Rate of permanent pacemaker implantation was 14.3 % (3/21). No paravalvular leakage ≥ grade II was detectable.
Conclusions
Preliminary experience suggests implantation of this type of THV in aortic annuli up to 32 mm to be feasible and safe, in particular calcification patterns. It does not result in a relevant incidence of PVL ≥ grade II, or increased rate of VARC-2 adjudicated clinical endpoints. Also, functional outcomes regarding transvalvular gradients or EOA demonstrate applicability of this THV in such patients.
Similar content being viewed by others
Abbreviations
- EOA:
-
Effective orifice area
- logEuroSCORE:
-
Logistic European System for Cardiac Operative Risk Evaluation
- LVOT:
-
Left ventricular outflow tract
- MSCT:
-
Multi-slice computed tomography
- NYHA:
-
New York Heart Association
- PVL:
-
Paravalvular leakage
- S3:
-
Edwards Sapien 3
- SAVR:
-
Surgical aortic valve replacement
- STS PROM:
-
Society of Thoracic Surgeons Predicted Risk of Mortality
- TA:
-
Transapical
- TAVI:
-
Transcatheter aortic valve implantation
- Tax:
-
Transaxilary
- TEE:
-
Transesophageal echocardiography
- TF:
-
Transfemoral
- THV:
-
Transcatheter heart valve
- TTE:
-
Transthoracic echocardiography
- TVL:
-
Transvalvular leakage
- VARC:
-
Valve Academic Research Consortium
References
Smith CR, Leon MB, Mack MJ et al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364(23):2187–2198
Makkar RR, Fontana GP, Jilaihawi H et al (2012) Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 366(18):1696–1704
Vahanian A, Alfieri O, Andreotti F et al ESC Committee for Practice Guidelines (CPG); Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version (2012) The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2012(42):S1–S44
Nishimura RA, Otto CM, Bonow RO et al (2014) 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63(22):2438–2488
Holzamer A, Sitka E, Hengstenberg C et al (2015) Multislice computed tomography-based prediction of the implantation plane in transcatheter aortic valve implantation: determination of the line of perpendicularity and the implanter’s views. Eur J Cardiothorac Surg 48(6):879–886
Schmidkonz C, Marwan M, Klinghammer L et al (2014) Interobserver variability of CT angiography for evaluation of aortic annulus dimensions prior to transcatheter aortic valve implantation (TAVI). Eur J Radiol 83(9):1672–1678
Staubach S, Franke J, Gerckens U et al (2013) Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry. Catheter Cardiovasc Interv 81(2):348–355
Husser O, Holzamer A, Resch M et al (2013) Prosthesis sizing for transcatheter aortic valve implantation—comparison of three dimensional transesophageal echocardiography with multislice computed tomography. Int J Cardiol 168(4):3431–3438
Leber AW, Eichinger W, Rieber J et al (2013) MSCT guided sizing of the Edwards Sapien XT TAVI device: impact of different degrees of oversizing on clinical outcome. Int J Cardiol 168(3):2658–2664
Mylotte D, Andalib A, Thériault-Lauzier P et al (2015) Transcatheter heart valve failure: a systematic review. Eur Heart J 36(21):1306–1327
Schymik G, Schröfel H, Heimeshoff M et al (2015) How to adapt the implantation technique for the new SAPIEN 3 transcatheter heart valve design. J Interv Cardiol 28(1):82–89
Seiffert M, Franzen O, Conradi L et al (2010) Series of transcatheter valve-in-valve implantations in high-risk patients with degenerated bioprostheses in aortic and mitral position. Catheter Cardiovasc Interv 76:608–615
Kappetein AP, Head SJ, Généreux P et al (2012) Valve Academic Research Consortium (VARC)-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 42:S45–S60
Cerillo AG, Mariani M, Berti S, Glauber M (2012) Sizing the aortic annulus. Ann Cardiothorac Surg 1(2):245–256
Zamorano JL, Gonçalves A, Lang R (2014) Imaging to select and guide transcatheter aortic valve implantation. Eur Heart J 35(24):1578–1587
Yang TH, Webb JG, Blanke P et al (2015) Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT. JACC Cardiovasc Interv 8(3):462–471
Koos R, Mahnken AH, Dohmen G et al (2011) Association of aortic valve calcification severity with the degree of aortic regurgitation after transcatheter aortic valve implantation. Int J Cardiol 150(2):142–145
Haensig M, Rastan AJ (2012) Aortic valve calcium load before TAVI: is it important? Ann Cardiothorac Surg 1(2):160–164
Schymik G, Heimeshoff M, Bramlage P et al (2014) Ruptures of the device landing zone in patients undergoing transcatheter aortic valve implantation: an analysis of TAVI Karlsruhe (TAVIK) patients. Clin Res Cardiol 103(11):912–920
Hayashida K, Bouvier E, Lefèvre T et al (2013) Potential mechanism of annulus rupture during transcatheter aortic valve implantation. Catheter Cardiovasc Interv 82(5):E742–E746
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Lenard Conradi, Hendrik Treede and Ulrich Schaefer are consultants for Edwards Lifesciences.
Rights and permissions
About this article
Cite this article
Schaefer, A., Linder, M., Treede, H. et al. Applicability of next generation balloon-expandable transcatheter heart valves in aortic annuli exceeding formally approved dimensions. Clin Res Cardiol 105, 585–591 (2016). https://doi.org/10.1007/s00392-015-0954-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-015-0954-9